
Preparation and characterization of doxorubicin-loaded microcapsules
RAO Jun; TAO Xia; CHEN JianFeng
Journal of Beijing University of Chemical Technology ›› 2008, Vol. 35 ›› Issue (4) : 69-72.
Preparation and characterization of doxorubicin-loaded microcapsules
Doxorubicin (DOX)-loaded poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microcapsules have been prepared by a double emulsion technique and characterized by dynamic laser light scattering, scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). SEM showed that the microcapsules had a size of ca. 900nm and smooth spherical surfaces. CLSM images directly verified that DOX was encapsulated into the microcapsules. The entrapment ratio of DOX in the capsules amounted to 35.7%. The effects of varying the preparation conditions on the microcapsule size and DOX encapsulation efficiency were also investigated. Drug release studies in a physiological environment indicated that the controlled release of DOX from the microcapsules could be sustained for over 10?days.
[1]Ventatraman S S, Pan J, Feng M, et al. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier[J]. International Journal of Pharmaceutics, 2005, 298(1): 219-232.
[2]Ruan G, Feng S S. Preparation and characterization of poly (lactic acid)-poly (ethylene glycol)-poly (lactic acid) ( PLA-PEG-PLA)microspheres forcontrolled release of paclitaxel[J]. Biomaterials, 2003, 24(27):5037-5044.
[3]Li Xiaohong, Deng Xiaomo, Yuan Minglong, et al. In vitro degradation and release profiles of poly-dl-lactide poly(ethylene glycol) microspheres with entrapped proteins[J]. Journal of Applied Polymer Science, 2000, 78: 140-148.
[4]杨远,贾文祥,祁欣,等. 可生物降解材料作为基因载体的研究[J]. 生物医学工程学杂志,2006,23(3):573-577.
[5]牛文强,傅国旗,吴俊丽,等. PLA/PEG/PLA三嵌段共聚物载药纳米胶囊的制备及表征[J]. 高等学校化学学报,2005,26(7):1369-1371.
[6]Dos Santos R A, Takahashi C S. Anticlastogenic and antigenotoxic effects of selenomethionine on doxorubicininduced damage in vitro in human lymphocytes[J]. Food and Chemical Toxicology, 2008, 46(2): 671-677.
[7]Omelyanenko V, Kope ˇková P, Gentry C, et al. Targetable HPMA copolymer-adriamycin conjugates: recognition, internalization and subcellular fate[J]. Journal of Controlled Release, 1998, 53(1-3): 25-37.
[8]林本兰,沈晓东,崔升,等. 磁性纳米粒阿霉素微球制备的初探[J]. 中国医院药学杂志, 2005, 25(5): 424-426.
[9]李范珠,胡晋. 阿霉素纳米囊的制备工艺及其毒性试验[J]. 中国现代医用药学杂志,2006, 23(6): 474-477.
[10]Yeo Y, Back N, Park K. Microencapsulation method for delivery of protein drug[J]. Biotechnol Bioprocess Eng, 2001, 6:213-230.
[11]Jain R A. The manufacturing techniques of various drug loaded biodegradable PLGA devices[J]. Biomaterials,2000,21(23):2475-2490.
[12]Meng Fentao, Ma Guanghui, Qiu Wei, et al. W/O/W double emulsion technique using ethyl acetate as organic solvent:effects of its diffusion rate on the characteristics of microparticles[J]. Journal of controlled release,2003,91(3):407-416.
[13]赵瑞玲,谢茵,丁红. 紫外分光光度法测定阿霉素聚乳酸微球含量[J]. 山西医科大学学报,2003, 34(2): 166-167.
/
〈 |
|
〉 |